Addressing Lung Cancer in belgium: A Proactive Approach

lung cancer remains a significant health challenge in belgium, with approximately 9,400 new cases diagnosed annually. it accounts for a staggering 20% of all cancer-related deaths in the country. Though, recent research indicates that early detection through low-dose CT scans can substantially improve outcomes. In response, a groundbreaking pilot project named “Zoralcs” has been launched to explore the feasibility of widespread lung cancer screening.

The Zoralcs Project: Pioneering Lung Cancer Screening

The Zoralcs project, spearheaded by Dr. Annemiek Snoeckx, a pulmonologist at the University Hospital Antwerp (UZA), aims to evaluate the practicality and potential challenges of implementing a population-wide lung cancer screening program. This initiative seeks to identify high-risk individuals and offer them early detection opportunities through advanced imaging technology.

Targeting High-risk Individuals: A Data-Driven Approach

Approximately 25,000 residents from six municipalities—Edegem, Mortsel, Kontich, Boechout, Lint, and Hove—are being invited to participate in the Zoralcs pilot project.Potential participants are asked to complete an online questionnaire if they have smoked more than 100 cigarettes in their lifetime. An algorithm then assesses their risk of developing lung cancer, considering factors such as smoking history, family history of cancer, and other relevant health parameters.

Low-Dose CT Scans: A Safe and Effective Screening Tool

Individuals identified as being at increased risk are offered a free low-dose CT scan at the UZA. These scans utilize a substantially lower radiation dose compared to conventional CT scans, minimizing potential harm while effectively detecting early-stage tumors. Early detection allows for a broader range of treatment options and significantly improves the chances of successful outcomes.

It is a simple and fast research, with less radiation dose than a classic CT scan

Guido van Hal, Sociologist and Expert in Screening Programs

AI-Powered Image Analysis: enhancing Diagnostic Accuracy

Radiologists leverage sophisticated AI software to analyze the CT scan images. This technology not only aids in identifying potential lesions but also quantifies their volume, enabling the faster detection of tumor growth. This integration of AI enhances the accuracy and efficiency of the screening process.

Comprehensive Support: Smoking Cessation Guidance

Recognizing the critical role of smoking cessation in lung cancer prevention, the Zoralcs project also provides support for participants who currently smoke or have recently quit. This comprehensive approach aims to address both early detection and primary prevention.

Anticipated Outcomes: A Vision for the future of Lung Cancer Care

The results of the Zoralcs pilot project are expected between 2027 and 2028. If successful, the program might potentially be expanded across Flanders. This widespread implementation has the potential to save countless lives and reduce healthcare costs by minimizing the need for extensive cancer treatments. The ultimate goal of Zoralcs is to demonstrate the feasibility and effectiveness of lung cancer screening, paving the way for a significant reduction in lung cancer mortality rates.

collaborative Effort: A Multi-Stakeholder Partnership

The Zoralcs project is a collaborative effort involving the University of Antwerp (Uantwerpen), the UZA, local authorities, digital support centers, general practitioners, pharmacists, social welfare centers (OCMWs), and other primary care providers. This multi-faceted partnership ensures comprehensive support for participants and facilitates the seamless integration of the screening program into the existing healthcare infrastructure.